A recombinant viruslike particle influenza A (H7N9) vaccine.
Novavax, Gaithersburg, MD lfries@novavax.com.
Louis F
LF
Fries
Gale E
GE
Smith
Gregory M
GM
Glenn
D000276:Adjuvants, Immunologic; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D064766:Influenza A Virus, H7N9 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000517:prevention & control* / Q000821:virology; D016037:Single-Blind Method; D014614:Vaccines, Synthetic / Q000276:immunology
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D007252:Influenza Vaccines; D014614:Vaccines, Synthetic